113 related articles for article (PubMed ID: 25081338)
41. Single-nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case-control study.
Wang XZ; Tang WZ; Su QY; Yao JG; Huang XY; Long QQ; Wu XM; Xia Q; Long XD
Cancer Med; 2019 Dec; 8(18):7869-7880. PubMed ID: 31663692
[TBL] [Abstract][Full Text] [Related]
42. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract][Full Text] [Related]
43. Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma.
Liu S; An J; Lin J; Liu Y; Bao L; Zhang W; Zhao JJ
PLoS One; 2014; 9(3):e92791. PubMed ID: 24676133
[TBL] [Abstract][Full Text] [Related]
44. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
45. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
[TBL] [Abstract][Full Text] [Related]
46. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase.
Pollard PJ; Wortham NC; Tomlinson IP
Ann Med; 2003; 35(8):632-9. PubMed ID: 14708972
[TBL] [Abstract][Full Text] [Related]
47. Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome.
Wang C; Zhang F; Fan H; Peng L; Zhang R; Liu S; Guo Z
Biochem Biophys Res Commun; 2011 Mar; 406(3):493-6. PubMed ID: 21345333
[TBL] [Abstract][Full Text] [Related]
48. IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing.
Lee JH; Shin DH; Park WY; Shin N; Kim A; Lee HJ; Kim YK; Choi KU; Kim JY; Yang YI; Lee CH; Sol MY
World J Surg Oncol; 2017 Apr; 15(1):82. PubMed ID: 28403884
[TBL] [Abstract][Full Text] [Related]
49. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
51. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
52. ATXN7 Gene Variants and Expression Predict Post-Operative Clinical Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Han C; Yu L; Liu X; Yu T; Qin W; Liao X; Liu Z; Lu S; Chen Z; Su H; Zhu G; Qin X; Gui Y; Li J; Xiao K; Chen X; Ye X; Peng M; Dong J; Peng T
Cell Physiol Biochem; 2016; 39(6):2427-2438. PubMed ID: 27855399
[TBL] [Abstract][Full Text] [Related]
53. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
[TBL] [Abstract][Full Text] [Related]
54. Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma.
Lee SH; Chung YH; Kim JA; Lee D; Jin YJ; Shim JH; Jang MK; Cho EY; Shin ES; Lee JE; Park NH; Yu E; Lee YJ
Liver Int; 2012 Mar; 32(3):457-66. PubMed ID: 22098246
[TBL] [Abstract][Full Text] [Related]
55. The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry.
Liu X; Si W; He L; Yang J; Peng Y; Ren J; Liu X; Jin T; Yu H; Zhang Z; Cheng X; Zhang W; Xia L; Huang Y; Wang Y; Liu S; Shan L; Zhang Y; Yang X; Li H; Liang J; Sun L; Shang Y
Signal Transduct Target Ther; 2021 Nov; 6(1):375. PubMed ID: 34728602
[TBL] [Abstract][Full Text] [Related]
56. The role of mutation of metabolism-related genes in genomic hypermethylation.
Waterfall JJ; Killian JK; Meltzer PS
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):16-23. PubMed ID: 25111818
[TBL] [Abstract][Full Text] [Related]
57. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
[TBL] [Abstract][Full Text] [Related]
58. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
Ma S; Yang J; Song C; Ge Z; Zhou J; Zhang G; Hu Z
PLoS One; 2017; 12(3):e0173700. PubMed ID: 28339471
[TBL] [Abstract][Full Text] [Related]
59. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
60. Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
Makkoch J; Praianantathavorn K; Sopipong W; Chuaypen N; Tangkijvanich P; Payungporn S
Asian Pac J Cancer Prev; 2016; 17(2):591-5. PubMed ID: 26925648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]